Considering Cost-Effectiveness in Cardiology Clinical Guidelines: Progress and Prospects

Area of Science:

• Cardiovascular Medicine
• Health Economics
• Clinical Practice Guideline Development

Background:

• Cardiologists have historically led clinical practice guideline development since the 1980s.
• The American College of Cardiology (ACC) and American Heart Association (AHA) have refined their guideline process over decades.
• Guidelines have shifted focus from procedures to clinical conditions and emphasize evidence-based decision-making.

Purpose of the Study:

• To describe the evolution of ACC/AHA guideline development.
• To highlight the increasing importance of incorporating economic considerations and value assessment.
• To outline the future integration of economic value into guideline recommendations.

Main Methods:

• Review of the historical development and organizational structure of ACC/AHA guidelines.
• Analysis of the shift from procedure-focused to condition-focused guidelines.
• Examination of the formalization of economic considerations and value assessment in guideline creation.

Main Results:

• The ACC/AHA guideline development process is now formalized, evidence-based, and manages conflicts of interest.
• There is a recognized need to make cost considerations more transparent and explicitly cite economic value.
• Future ACC/AHA guidelines will incorporate value assessment, including the review of published economic assessments.

Conclusions:

• The ACC/AHA are formally integrating economic value into their clinical practice guidelines.
• This represents a significant evolution towards evidence-based recommendations that consider societal costs.
• The process will involve assessing evidence quality and defining value levels for future cardiovascular care recommendations.